Functionalized amino acids - inibitors of GABA uptake with antianalgetic activity

2014/15/B/NZ7/00930

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia
  • ST5_16: Chemia biologiczna

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Paula Magdalena Zaręba

Number of co-investigators in the project: 8

Call

OPUS 8 – announced on 2014-09-15

Amount awarded
691 943 PLN
Project start date
2015-07-13
Project end date
2020-12-12
Project duration
65 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. -.
  2. Analgezymetr do pomiaru bólu spontanicznego. Cost: 32 000 PLN
  3. Chłodziarka zanurzeniowa. Cost: 30 000 PLN
  4. Homogenizator ultradźwiękowy. Cost: 30 000 PLN
  5. Liofilizator wraz z pompą.
  6. Wyparka rotacyjna z systemem próżniowym, pokrywą ochonną, łaźnią oraz termostatem cyrkulacynym. Cost: 55 000 PLN

Information in the final report

Publication in academic press/journals (7)

  1. Novel functionalized amino acids as inhibitors of GABA transporters with analgesic activity

    Authors:
    Gryzło Beata; Zaręba Paula; Malawska Katarzyna; Mazur Gabriela; Rapacz Anna; Łątka Kamil; Höfner Georg; Sałat Kinga; Latacz Gniewomir; Bajda Marek; Wanner Klaus; Malawska Barbara; Kulig Katarzyna
    Academic press:
    ACS Chemical Neuroscience (year: 2021, volume: brak danych, pages: brak danych), Publisher: ACS Publications
    Status:
    Published
    DOI:
    10.1021/acschemneuro.1c00351 – link to the publication
  2. Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity

    Authors:
    Paula Zaręba, Kinga Sałat, Georg C. Höfner, Kamil Łątka, Marek Bajda, Gniewomir Latacz, Krzysztof Kotniewicz, Anna Rapacz, Adrian Podkowa, Maciej Maj, Krzysztof Jóźwiak, Barbara Filipek, Klaus T. Wanner, Barbara Malawska, Katarzyna Kulig
    Academic press:
    European Journal of Medicinal Chemistry (year: 2020, volume: 221, pages: 113512), Publisher: Elsevier
    Status:
    Published
  3. Studies on the Activity of Selected Highly Lipophilic Compounds toward hGAT1 Inhibition. Part II.

    Authors:
    Nowaczyk A, Fijałkowski Ł, Kowalska M, Podkowa A, Sałat K
    Academic press:
    ACS Chemical Neuroscience (year: 2019, volume: 10 (1), pages: 337–347), Publisher: ACS Publications
    Status:
    Published
    DOI:
    10.1021/acschemneuro.8b00282 – link to the publication
  4. Development, recent achievements and current directions of research into GABA uptake inhibitors

    Authors:
    Paula Zaręba, Beata Gryzło, Gabriela Mazur, Barbara Malawska
    Academic press:
    Current Medicinal Chemistry (year: 2021, volume: 28, pages: 750-776), Publisher: BenthamScience
    Status:
    Published
    DOI:
    10.2174/0929867325666191010120236 – link to the publication
  5. Docking and pharmacodynamic studies on hGAT1 inhibition activity in the presence of selected neuronal and astrocytic inhibitors. Part I.

    Authors:
    Nowaczyk A, Fijałkowski Ł, Zaręba P, Sałat K
    Academic press:
    Journal of Molecular Graphics and Modelling (year: 2018, volume: 85, pages: 171-181), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.jmgm.2018.09.003 – link to the publication
  6. Experimental Drugs for Neuropathic Pain

    Authors:
    Salat K, Gryzlo B, Kulig K
    Academic press:
    Current Neuropharmacology (year: 2018, volume: 16(8), pages: 1193-1209), Publisher: Bentham Science
    Status:
    Published
    DOI:
    10.2174/1570159X16666180510151241 – link to the publication
  7. Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice

    Authors:
    Paula Zaręba, Beata Gryzło, Katarzyna Malawska, Kinga Sałata, Georg C. Höfner, Alicja Nowaczyk, Łukasz Fijałkowski, Anna Rapacz, Adrian Podkowa, Anna Furgała, Paweł Żmudzki, Klaus T. Wanner, Barbara Malawska, Katarzyna Kulig
    Academic press:
    European Journal of Medicinal Chemistry (year: 2020, volume: 188, pages: 111920), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejmech.2019.111920 – link to the publication

Articles in post-conference publications (2)

  1. Design, synthesis and evaluation of 2-substituted derivatives of butanamides as gaba uptake inhibitors. Elucidation of the structure-activity studies.

    Authors:
    Paula Zaręba, Kinga Sałat, Georg Hoefner, Adrian Podkowa, Klaus T. Wanner, Katarzyna Kulig
    Conference:
    5th SEQT Medicinal Chemistry Summer School Medicinal Chemistry in Drug Discovery: the Pharma Perspective (year: 2016, pages: 122), Publisher: SEQT
    Date:
    conference 14-16.06.2016
    Status:
    Published
  2. 4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl derivatives of N-benzylamides as mGAT3/4 inhibitors with analgesic activity

    Authors:
    Paula Zaręba, Beata Gryzło, Katarzyna Malawska, Kinga Sałat, Georg C. Höfner, Anna Rapacz, Adrian Podkowa, Anna Furgała, Klaus T. Wanner, Barbara Malawska, Katarzyna Kulig
    Conference:
    EFMC-ISMC & EFMC-YMCS Virtual Poster Session (year: 2020, pages: 156), Publisher: LD Organisation srl
    Date:
    conference 7-11.09.2020
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski